How to Summarize the Safety Profile of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy?
Author:
Affiliation:
1. Takahiro Hasegawa, Shionogi & Co, Ltd, Osaka, Japan; Hajime Uno, Dana-Farber Cancer Institute, Boston, MA; Lee-Jen Wei, Harvard University, Boston, MA
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2016.67.2055
Reference5 articles.
1. A Randomized, Open-Label, Multicenter, Phase III Study of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
2. Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis
3. Alternatives to Hazard Ratios for Comparing the Efficacy or Safety of Therapies in Noninferiority Studies
4. Comparison of Treatment Effects Measured by the Hazard Ratio and by the Ratio of Restricted Mean Survival Times in Oncology Randomized Controlled Trials
5. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Determination of hazard ratio for progression‐free survival considering the tumor assessment schedule in sample size calculation;Pharmaceutical Statistics;2020-02-17
2. Methods for Accommodating Nonproportional Hazards in Clinical Trials: Ready for the Primary Analysis?;Journal of Clinical Oncology;2019-12-10
3. Assessing Clinical Equivalence in Oncology Biosimilar Trials With Time-to-Event Outcomes;JNCI Cancer Spectrum;2019-08-01
4. Reply to T. Hasegawa et al and I. Gross et al;Journal of Clinical Oncology;2016-11-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3